![Alexander Macrae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Macrae
Directeur Général chez
SANGAMO THERAPEUTICS, INC.
Fortune : 304 584 $ au 31/05/2026
Profil
Alexander D.
Macrae is President, Chief Executive Officer & Director at Sangamo Therapeutics, Inc. since 2016.
Dr. Macrae is a Member of The Royal College of Physicians.
Former roles include Independent Non-Executive Director at 4D Pharma Plc from 2019 to 2023, Global Medical Officer at Takeda Pharmaceuticals U.S.A., Inc. from 2012 to 2016, and Senior VP-Emerging Markets Research & Development at GlaxoSmithKline LLC from 2009 to 2012.
Education includes an undergraduate degree from the University of Glasgow in 1986 and a doctorate from King's College, Cambridge in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/05/2026 | 1 397 174 ( 0,34 % ) | 304 584 $ | 31/05/2026 |
Postes actifs de Alexander Macrae
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur Général | 01/06/2016 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Alexander Macrae
| Sociétés | Poste | Fin |
|---|---|---|
| 4D PHARMA PLC | Directeur/Membre du Conseil | 15/03/2023 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/03/2016 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/01/2012 |
Formation de Alexander Macrae
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
King's College, Cambridge
 King's College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
